Buprenorphine: Difference between revisions
No edit summary |
No edit summary |
||
| Line 45: | Line 45: | ||
Opioid dependence: nitially 0.8-4mg on first day, usual dose 12-24mg QD, max 32mg | Opioid dependence: nitially 0.8-4mg on first day, usual dose 12-24mg QD, max 32mg | ||
'''Doses in children | |||
''Intramuscular or slow intravenous'' : 6 months to 12 years: 3 to 6 micrograms/kg every 6 to 8 hours; up to 9 micrograms/kg if required in refractory cases. | |||
Sublingual route is licensed in children aged from 6 to 12 years: | |||
#16 to 25 kg: 100 micrograms | |||
#25 to 37.5 kg: 100 to 200 micrograms | |||
#37.5 to 50 kg: 200 to 300 micrograms | |||
Older children may be given the usual adult dose. | |||
Revision as of 23:38, 4 October 2020
Buprenorphine is an opioid analgesic. It is used for the relief of moderate to severe pain and as an adjunct to anaesthesia. It is also used in the treatment of opioid dependence.
Transdermal buprenorphine patches is used for chronic intractable cancer pain and neuropathic pain. However, this route is not suitable for the treatment of acute pain.
| Generic Name 藥名 | HA Code 藥物代碼 | Classification藥物分類 |
|---|---|---|
| Burponorphine | DD |
Mechanism of Action
Pain relief
opioid dependence
| Route of Administration | IV |
|---|
Dosage
For chronic moderate to severe pain
Intramuscular : analgesia is apparent within 15 minutes and lasts up to 6 hours.
A slower, more prolonged response is achieved after sublingual doses. The analgesic effects of buprenorphine after transdermal application may not be seen for at least 12 to 24 hours.
Buprenorphine is given by all the above routes for relief of moderate and severe pain.
- Intramuscular or slow intravenous : 300 to 600 micrograms every 6 to 8 hours as required.
- Transmucosal : sublingual doses of 200 to 400 micrograms every 6 to 8 hours as required.
- Transdermal patches : doses should be individually titrated according to previous opioid usage. Patches are not appropriate for acute pain.
Use of a patch providing 35 micrograms/hour of buprenorphine is roughly equivalent to 30 to 60 mg daily of oral morphine sulphate.
For the treatment of opioid dependence , buprenorphine is given by the oral transmucosal route,
Sublingually : the initial dose is 0.8 to 4 mg once daily. The dose may be increased as necessary but maintenance doses should not exceed 32 mg daily.
Moderate to severe pain: 200-400 mcg q6-8h PRN
Opioid dependence: nitially 0.8-4mg on first day, usual dose 12-24mg QD, max 32mg
Doses in children
Intramuscular or slow intravenous : 6 months to 12 years: 3 to 6 micrograms/kg every 6 to 8 hours; up to 9 micrograms/kg if required in refractory cases.
Sublingual route is licensed in children aged from 6 to 12 years:
- 16 to 25 kg: 100 micrograms
- 25 to 37.5 kg: 100 to 200 micrograms
- 37.5 to 50 kg: 200 to 300 micrograms
Older children may be given the usual adult dose.
